| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.15 | 0.6 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.2 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |